MedPath

Phendimetrazine

Generic Name
Phendimetrazine
Brand Names
Fendique
Drug Type
Small Molecule
Chemical Formula
C12H17NO
CAS Number
634-03-7
Unique Ingredient Identifier
AB2794W8KV

Overview

Phendimetrazine is a weight loss medication. Phendimetrazine is chemically related to amphetamines and is a Schedule III drug under the Convention on Psychotropic Substances and in the US since 1970.

Background

Phendimetrazine is a weight loss medication. Phendimetrazine is chemically related to amphetamines and is a Schedule III drug under the Convention on Psychotropic Substances and in the US since 1970.

Indication

Used in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.

Associated Conditions

  • Exogenous Obesity

Clinical Trials

FDA Approved Products

Phendimetrazine Tartrate
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:105 mg in 1 1
Approved: 2012/04/10
NDC:54868-3071
Phendimetrazine Tartrate
Manufacturer:Preferred Pharmaceuticals Inc.
Route:ORAL
Strength:35 mg in 1 1
Approved: 2023/08/25
NDC:68788-7236
Phendimetrazine Tartrate
Manufacturer:Blenheim Pharmacal, Inc.
Route:ORAL
Strength:35 mg in 1 1
Approved: 2015/03/12
NDC:10544-041
Phendimetrazine Tartrate
Manufacturer:Rebel Distributors Corp
Route:ORAL
Strength:35 mg in 1 1
Approved: 2009/06/01
NDC:21695-597
Phendimetrazine Tartrate
Manufacturer:A-S Medication Solutions
Route:ORAL
Strength:35 mg in 1 1
Approved: 2019/12/11
NDC:50090-6552

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath